Patient‐Reported Outcome Measures in Musculoskeletal Oncology: Current Concepts, Barriers, and the Future
Abstract
ABSTRACT Patient‐reported outcome measures (PROMs) remain underutilized in musculoskeletal oncology, with only 4.9% of tumor‐focused articles incorporating them. This review synthesizes current PROM instruments—including Toronto Extremity Salvage Score, PROMIS, and emerging tools such as the Sarcoma Assessment Measure—and identifies barriers unique to this population, including psychological distress, workflow complexity, and disease heterogeneity. Future directions include flexible baseline collection, EHR‐integrated dashboards, national registry linkage, wearable technology, and AI‐driven processing to increase PROMs utilization.